Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice by Damy, Sueli B et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Mycoplasma pneumoniae and/or Chlamydophila pneumoniae 
inoculation causing different aggravations in cholesterol-induced 
atherosclerosis in apoE KO male mice
Sueli B Damy1, Maria L Higuchi*2, Jorge Timenetsky3, Márcia M Reis2, 
Suely P Palomino2, Renata N Ikegami2, Fabiana P Santos4, Junko T Osaka1 
and Luiz P Figueiredo1
Address: 1Medical School, University of Sao Paulo/LIM 26, Sao Paulo, Brazil, 2Heart Institute (InCor) of Clinical Hospital, University of Sao Paulo, 
Sao Paulo, Brazil, 3Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil and 4Adolfo Lutz Institute, Sao Paulo, Brazil
Email: Sueli B Damy - damy@usp.br; Maria L Higuchi* - anplourdes@incor.usp.br; Jorge Timenetsky - joti@usp.br; 
Márcia M Reis - anpmarcia@incor.usp.br; Suely P Palomino - anpsuely@incor.usp.br; Renata N Ikegami - renata.ikegami@incor.usp.br; 
Fabiana P Santos - fcpereir@usp.br; Junko T Osaka - osaka@usp.br; Luiz P Figueiredo - lpoli@uol.com.br
* Corresponding author    
Abstract
Background: Chamydophila pneumoniae (CP) and/or Mycoplasma pneumoniae (MP) are two bacteria detected in
vulnerable atheromas. In this study we aimed to analyze whether CP and/or MP aggravates atherosclerosis
induced by cholesterol-enriched diet in C57BL/6 apoE KO male mice. Thirty male apoE KO mice aged eight weeks
fed by a diet containing 1% cholesterol until 32 weeks of age were divided into four groups: the first was
inoculated with CP (n = 7), the second with MP (n = 12), the third with both CP + MP (n = 5), and the fourth
with saline (sham n = 6). The animals were re-inoculated at 36 weeks of age, and sacrificed at 40 weeks of age.
Two ascending aorta and one aortic arch segments were sampled. In the most severely obstructed segment,
vessel diameter, plaque height, percentage of luminal obstruction and the degree of adventitial inflammation were
analyzed. The plaque area/intimal surface ratio was obtained by measuring all three segments. The adventitial
inflammation was semiquantified (0 absent, 1 mild, 2 moderate, and 3 diffuse).
Results: The mean and standard deviation of plaque height, % luminal obstruction, external diameter, the plaque
area/intimal surface ratio and the adventitial inflammation values are the following for each group: MP (0.20 +/-
0.12 mm, 69 +/- 26%, 0.38 +/- 0.11 mm, 0.04 +/- 0.04 and 0.22 +/- 0.67), CP (0.23 +/- 0.08 mm, 90 +/- 26%, 0.37
+/- 0.08 mm, 0.04 +/- 0.03, and 0.44 +/- 0.53), MP + CP (18 +/- 0.08 mm, 84 +/- 4.0%, 0.35 +/- 0.25 mm, 0.03 +/
- 0.03 and 1.33 +/- 0.82) and sham (0.08 +/- 0.09 mm, 42 +/- 46%, 0.30 +/- 0.10 mm, 0.02 +/- 0.03 and 0.71 ±
0.76). A wider area of plaque/intimal surface was observed in MP + CP inoculated groups (p = 0.07 and 0.06) as
well as an increased plaque height in CP (p = 0.01) in comparison with sham group. There was also an increased
luminal obstruction (p = 0.047) in CP inoculated group in comparison to sham group. Adventitial inflammation in
MP + CP inoculated group was higher than MP, CP and the sham groups (p = 0.02).
Conclusion: Inoculation of CP, MP or both agents in C57BL/6 apoE KO male mice caused aggravation of
experimental atherosclerosis induced by cholesterol-enriched diet, with distinct characteristics. CP inoculation
increased the plaque height with positive vessel remodeling and co-inoculation of MP + CP caused the highest
adventitial inflammation measures.
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Background
Atherosclerosis is considered an arterial inflammatory dis-
ease resulting from lipid entrance in the vascular wall and
subsequent oxidation. Lipid oxidation has been related to
infectious agents [1], mainly Chlamydophila or Chlamydia
pneumoniae (CP) [2-4]. CP induced or accelerated athero-
sclerosis in experimental animals [5-7]. Although more
than 700 studies have been published focusing CP in
atherosclerosis, the inconsistent results of clinical trials
using antibiotic therapy discouraged the infection theory.
However, our previous studies have shown that co-infec-
tion of CP and Mycoplasma pneumoniae (MP) is usually
present in atherosclerotic plaques, in greater amount in
ruptured plaques [8,9]. The co-infection theory is corrob-
orated by the recent finding of increased serum antibodies
to MP and CP in patients with atherosclerosis and acute
myocardial infarction [10,11]. Fibrous cap stabilizes
human atherosclerotic plaques and we found that plaque
fibrosis is related to increased growth factors and higher
proportion of MP to CP [12]. On the other hand, predom-
inance of CP in such co-infection is related to plaque rup-
ture.  Mycoplasma  is the smallest self-replicating
microorganism having particular characteristics as choles-
terol requirement for growth, drawing the host for
immune depression [13] and increase the pathogenicity
of co-infective agents [14]. Association of different micro-
organisms in a host may increase the virulence among
them [15,16] and may explain the disappointing clinical
trial results with anti-chlamydial antibiotic therapy
[17,18].
The objective of the present study was to verify whether
inoculation of MP or in association with CP aggravates
cholesterol-induced atherosclerosis in apoE KO mice. The
severity of atherosclerosis was evaluated by measuring the
plaque height, plaque fat area, intima and adventitia
inflammation and amount of plaque/surface of the vessel.
We also evaluated whether co-infection would cause
plaque rupture.
Results
The experimental infection caused six deaths in the 36
studied male mice: Among the death mice, four were inoc-
ulated with MP, one was inoculated with CP + MP and
one was from the sham group. By the end of the experi-
ment, the pooled serum were tested for total cholesterol,
HDL and LDL in all groups. The respective values were:
534, 350, 443 and 532; HDL 29, 20, 40, 21 and LDL 435,
215, 316 and 393 mg/dl. After 4 weeks the inoculated
mice showed serum antibody titers of: < 1:16 to CP, from
1:8 to 1:16 to MP and the sham did not show antibodies
to CP and MP. Electron microscopic of the intimal plaque
of a mouse inoculated with MP showed structures sugges-
tive of MP such as irregular rounded bodies with 0.1 to 0.4
m in diameter, lack of the cell wall, containing granular
chromatin-like material (Figure 1). One animal of the CP
+ MP inoculated group exhibited the structures of MP and
Electron microscopic views of Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) bodies Figure 1
Electron microscopic views of Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) bodies. Elemen-
tary bodies in the myocardial fiber from a mouse of the MP + CP infected group. The close view on the left side shows the 
double membrane of CP elementary bodies (1A). An intimal plaque from a mouse of the MP infected group, exhibiting two 
rounded mycoplasma bodies, characterized by only one envelopment membrane (1B).BMC Microbiology 2009, 9:194 http://www.biomedcentral.com/1471-2180/9/194
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the elementary bodies of CP in the myocardial fiber char-
acterized by rounded electron-dense bodies enveloped by
two membranes (Figure 1A and 1B).
Analysis of the extent and degree of atherosclerosis
Table 1 shows the mean and standard deviation of varia-
bles in the different groups. P value is the comparison of
the infected groups with the sham group, using One Way
Analysis of Variance and Dunn's Methods for non-nor-
mally distributed values or Bonferroni's test for normally
distributed values. Two significant differences was
observed: higher % of luminal obstruction in CP group
compared with sham group and higher adventitial inflam-
mation in the group co-infected with MP + CP compared
with infected only with MP.
In variables showing a trend to be different when compar-
ing simultaneously the 4 groups, Student T test was used
to compare the two groups with the highest difference. It
showed significant major plaque high in CP group than
the sham and a trend to have major plaque area/internal
surface in MP and CP groups than in sham group.
External diameter, which indicates vessel remodeling, did
not differ between infected versus sham groups. However,
the animals infected with CP or MP inoculums exhibited
more atheroma plaques on the intima surface (0.043 +/-
0.028 and 0.038 +/- 0.037 mm2/mm) than the sham
group (0.020 +/- 0.03 mm2/mm) with no statistical signif-
icant difference (p = 0.06 and p = 0.07, respectively). The
most severely obstructed atherosclerotic sites had
increased plaque height in the CP group compared with
sham and more adventitial inflammation in MP+CP
group, compared with MP group. There was not ruptured
plaque in any of the groups.
Discussion
The present study showed that intraperitoneal inoculation
of MP, CP or the both microbes aggravated atherosclerosis
induced by cholesterol-enriched-diet in apoE KO male
mice, as measured by plaque height, % luminal obstruc-
tion, adventitial inflammation and amount of plaque
area/internal surface. This study analyzed the ascending
aorta and aortic arch, which are segments of aorta that are
more prone to development of atherosclerosis [5]. CP
infection is associated with increased lymphocytic inflam-
mation [9]. Particular characteristics of mycoplasma
might contribute to different atheroma plaque outcomes:
Mycoplasma growth depends of cholesterol viability, this
microorganism has surface compounds that modulates
the host immune response, cause immunosuppression
and facilitates the proliferation of other infectious agents
[19]. However MP seems to inhibit CP growth [11].
Infection by CP and co-infection by MP + CP caused more
severe % luminal obstruction and adventitial inflamma-
tion than sham group or inoculation with only MP in
apoE KO mice fed cholesterol-enriched-diet. The severity
of % of luminal obstruction is a combination of plaque
height and vessel diameter. In CP group the plaque height
is high but probably associated with positive remodeling
as the external vessel diameter is larger than the sham
group. The MP + CP group presented smaller plaques but
without vessel remodeling, the external vessel diameter
presenting the same values than the sham group. The
hypothesis of a flattened lumen vessel due to a lack of fix-
ation of the vessel wall should be considered. The plaques
in MP group were also associated with positive vessel
remodeling. The lack of statistical significant difference in
the external vessel diameter that represents the degree of
vessel remodeling may be related with three factors: a)
large standard deviation values and b) the site chosen for
doing the measures: as exemplified in methods with the
Figure 2, section 3, it was not used the plaque height but
the lowest lumen value for choosing the site to be meas-
ured and c) some segments might be partially collapsed
due to a lack of perfusion fixation.
Table 1: Mean (SD) of variables in the cross-sections of aortic segments from infected and sham inoculated apoE KO mice
Group Plaque/internal 
surface Mean (SD)
External Diameter 
Mean (SD)
% obstruction
Mean (SD)
plaque height Inflammation 
adventitia (0 - 3+)
MP (n = 12) 0.038 (0.037) 0.38 (0.11) 69 (26) 0.20 (0.12) 0.22 (0.67)
CP (n = 7) 0.043 (0.028) 0.37 (0.11) 90(26) 0.23 (0.08) 0.44 (0.53)
MPCP (n = 5) 0.032 (0.027) 0.30 (0.11) 84 (4.0) 0.18 (0.08) 1.33 (0.82)
Sham inoculated 
(n = 6)
0.02 (0.03) 0.30 (0.11) 42 (46) 0.08 (0.09) 0.71 (0.76)
P 
(ANOVA and Dunn's 
test)
0.20 0.27 0.047 (CP vs Sham) 0.07 0.02 (MP vs MPCP)
P (T test) 0.07 (MP vs Sham)
0.06 (CP vs Sham)
0.012 (CP vs Sham)
MP - Mycoplasma pneumoniae, CP - Chlamydia pneumoniae, SD -Standard Deviation. P values correspond to ANOVA test and Dunn's, for non-
normally distributed values or Bonferroni's test for normally distributed values.BMC Microbiology 2009, 9:194 http://www.biomedcentral.com/1471-2180/9/194
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The interrelationship between these microbes and differ-
ent atheroma plaque morphology have already been
found in human plaques. Advanced coronary atheroma
plaques in humans showed that few CP and MP antigens
were detected in small and fibrotic plaques, which were
associated with negative vessel remodeling causing severe
obstruction, and on the contrary, vulnerable plaques were
rich in MP, increased adventitial inflammation that corre-
lated with the numbers of cells positive for CP [9]. Also,
in initial human atherosclerotic lesions, high MP/CP
ratios were associated with increased levels of growth fac-
tors and fibrosis and low number of macrophages [12].
Similarly, in the present study, inoculation of CP was
associated with increased plaque size, higher mean exter-
nal vessel diameter, which are characteristics of plaque
vulnerability as described in humans [9]. Favoring the co-
infectious theory, human clinical studies demonstrated
association of increased MP and CP antibody titers with
acute myocardial infarction patients [10,11,20].
Previous studies in the literature did not show aggravation
of atherosclerosis by intranasal CP inoculation in apoE
KO mice in a short follow-up period [5]. Intranasal Myco-
plasma pneumoniae inoculation in rabbits did not induce
atherosclerosis in a short follow-up period [21]. In com-
parison to presented findings, it is believed that differ-
ences in the route of inoculation of infectious agents
(intraperitoneal versus intranasal) and time of follow up
may explain these apparently conflicting results. It seems
that intraperitoneal inoculation is more efficient in dis-
seminating the infectious agents than intranasal inocula-
tion and also that the peritoneal route would make it
easier for infectious agents to reach the adventitia, which
An example of three aorta cross-sections, and how the measures were taken Figure 2
An example of three aorta cross-sections, and how the measures were taken. Three sections and the close view of 
section n°.1 corresponds to the most severely obstructed segment, where measurement of plaque height (red line) and exter-
nal diameter (green line) were performed (2A). The internal vessel perimeter measurement, represented by red dotted lines 
(2B) and the total plaque area, in yellow (2C).
B C
1
3
2
A
1
A
CBMC Microbiology 2009, 9:194 http://www.biomedcentral.com/1471-2180/9/194
Page 5 of 8
(page number not for citation purposes)
may be the main entrance for infectious agents. The
ultrastructural study, which was performed only in one
case for group, confirmed the presence of mycoplasma
cells in the plaque, and of CP elementary bodies in the
myocardial fibers, as well as of mycoplasma in the myo-
cardial extracellular matrix. These data suggested that the
studied infectious agents reached the circulation and
many organs. The aggravation of atherosclerosis is proba-
bly caused by elements derived from infectious agents
such as heat shock proteins or lipoproteins and not by
direct presence of these agents in the lesion [22]. The mice
fed with cholesterol enriched diet since the age of 8 weeks
were infected at the age of 32 weeks and sacrificed at 40
weeks of age. This quite late period for inoculation
increases the possibility that bacteria may be present in
the atheroma plaques only as innocent bystanders, as they
get a good breeding ground. However herein, the experi-
mentally infected mice groups showed increased severity
and different morphologies in atherosclerotic plaques
than non infected animals. The presented results strongly
point to that the studied infectious agents have a relevant
role in atherosclerosis aggravation inducing injury directly
by their presence in the plaques and/or indirectly by
immune system activation.
All the infected groups showed low titers of serum anti-
bodies to CP and MP. This is an expected result, since
chlamydia and mycoplasma infections usually do not
progress with high levels of antibodies probably due to
the microbe escape mechanisms from the immune
response [23,24]. Due to the small amount of blood col-
lected from each animal, an individual antibody serum
analysis could not be performed. The atherosclerosis was
correlated more with the cholesterol levels than the anti-
bodies to CP [25,26]. For this reason, the lack of individ-
ual animal antibody titers to CP or MP may be not so
relevant for the interpretation of the studied infection.
The progression of atherosclerosis may be influenced by
repeated microbe infections. Periods of increase and
decrease of atherosclerotic lesions are seen by angio-
graphic studies [27,28]. Bacterial lipopolysaccharides and
endotoxins, autoimmunity due to molecular mimetiza-
tion between the infectious agents, endovascular proteins
such as Heat Shock Proteins and the activation of toll-like
receptors by lipoproteins of the infectious agents are some
of the mechanisms attributed to the development of
inflammation and endothelial dysfunction in atherogen-
esis [29,30]. During both chronic and acute infections in
humans, HDL levels decrease and may aggravate athero-
sclerosis [30], since this lipoprotein is important in
reverse cholesterol transport and in the removal of oxidi-
zation products and inflammatory mediators from the cir-
culation. However, in apoE KO mice, the loss of the ligand
for lipid particle receptors is associated with an increase in
total cholesterol due to mainly LDL particle accumula-
tion. Basal cholesterolemia of apoE KO mice is up to five
times higher than that of animals of the same strain with-
out the genetic defect, that aggravate with cholesterol
enriched diet [31]. Development of atherosclerotic lesions
is also affected by cholesterol reverse transport in which
apoE plays a pivotal role. In our study, lower level of LDL
was seen in infected groups, mainly in MP group. How-
ever, the statistical analysis was not performed because we
analyzed a pool of sera from each group.
Plaque rupture is not usually present in experimental
atherosclerosis in animals including the apoE KO mice,
which are considered an adequate experimental model for
atherosclerosis studies [32]. In the present study it was not
found ruptured plaques either. In humans, vulnerable
plaques exhibited a third class of microbes, the Archaea
[33], in close association with CP and MP.
Conclusion
Intraperitoneal inoculation of Chlamydia pneumoniae
(CP),  Mycoplasma pneumoniae (MP) or both microbes
caused aggravation of experimental atherosclerosis
induced by cholesterol-enriched diet, with different char-
acteristics. MP or CP caused more extensive atheroscle-
rotic lesions in the aorta, CP resulted in increased plaque
height with positive vessel remodeling and co-inoculation
of MP + CP led to the development of more obstructive
lesions due to smaller plaques associated with no vessel
remodeling.
Methods
Animals
This study was approved by the Institutional Animal Wel-
fare and Use Committee (Authorization number: SDS
2371/03/165). Animals were treated in accordance with
the Guide for the Care and Use of Laboratory Animals
[34].
Colonies of C57BL/6 apoE KO mice were obtained from
original animals of Jackson Laboratories (Bar Harbor,
ME). The foundation colonies were maintained in a Trex-
ler isolator (Veco do Brasil, Campinas). Pups weaned at
21-days of age were housed in microisolator cages, under
biosafety level 2 conditions, with free access to sterile
water and regular irradiated rations. The mice were sero-
logically negative for murine cytomegalovirus (MCMV),
mouse hepatitis virus (MHV), minute virus of mice
(MVM), M. pulmonis, M. pneumoniae and C. pneumoniae.
The mice were inoculated intraperitoneally with either 1 ×
106 inclusion-forming units (IFU) of C. pneumoniae (CP),
AR-39 (ATCC 53592), kindly provided by Prof. Mário
Hirata of the Institute of Pharmaceutical Sciences of Sao
Paulo University, and/or 1 × 106 colony forming unitsBMC Microbiology 2009, 9:194 http://www.biomedcentral.com/1471-2180/9/194
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(CFU) of M. pneumoniae (MP) strain FH, (ATTC 15531),
from the Institute of Biomedical Sciences of Sao Paulo
University. Saline was the vehicle used to prepare the bac-
terial inoculum. The control group of non-infected mice
were inoculated only with 100 L of saline per mouse.
ApoE KO male mice aged 8-weeks were fed 1%-choles-
terol (Sigma - C8503)-enriched diet for 24 weeks. After
this period they were subdivided into four groups: a)
Group CP (n = 9) inoculated with CP; b) Group MP (n =
13) inoculated with MP; c) Group CP+MP (n = 7) inocu-
lated with CP and MP and d) Sham (n = 7) inoculated
with saline. The infected animals were re-inoculated 4
weeks later, and sacrificed after 4 weeks, at 40 weeks of
age.
At the end of the experiment, the mice were sedated with
Ketamin (Parke-Davis) 25 mg/kg and Xylazin (Bayer) 5
mg/kg. An intracardiac puncture into the base of the left
ventricle was performed with a 25-gauge, 3/4" needle to
withdraw 1 ml of blood. The aorta was then fixed by per-
fusion for 3 to 5 min of 10% buffered formalin under
physiological pressure. Two ascending aorta and one aor-
tic arch segments, avoiding the regions of artery branch
origin, were represented by three transversal rings, proc-
essed to be embedded in a single paraffin block, which
was sliced in 5 m serial sections and stained with Hema-
toxylin and Eosin and Masson's trichrome techniques.
A pool of sera from all animals in each group was
obtained and stored at -20°C. The levels of total choles-
terol and fractions were measured using an enzyme-
based, colorimetric kit (Celm, Sao Paulo, SP- Brazil). For
both CP and MP serum antibody quantitation, sera were
pooled and titrated by serial, 2-fold dilution. CP AR-39
strain, acquired from the American Type Culture Collec-
tion (Manassas- VA, USA) was cultured in a Hep-2 lineage
cells (Virology Section of the Adolfo Lutz Institute, Sao
Paulo SP- Brazil). Wells containing the Hep-2 cells with
CP inclusions were used to evaluate the antibody titers
against CP by an in-house indirect immunofluorescence
test, with fluorescein isothiocyanate-conjugated goat anti-
mouse IgG (Sigma, St. Louis, USA). MP antibodies were
detected by enzymatic inhibition as described elsewhere
[35].
Electron microscopy
One aorta fragment sectioned parallel to the first cross-
section and one myocardial fragment nearby the aorta of
the MP and CP + MP groups were sampled for electron
microscopic examination, fixed in 3% glutaraldehyde and
processed to be embedded in Araldite resin [36]. Thin sec-
tions were observed in a Philips EM-301 transmission
microscope (Eindhoven, Netherlands) looking for MP
cells and CP bodies in order to certify that the infection
had occurred. The ultrastructural study was performed
only in one case for group since it was not correlated with
the amount of infectious agent bodies in the plaque with
the aggravation of atherosclerosis, but only to verify
whether the inoculated microbes had entered the circula-
tion and reached the heart and artery walls.
Microscopic evaluation of atherosclerosis
Semi-quantitative analysis
A semi-quantitative analysis was performed in all three
aorta sections in the H&E slide by two independent
observers, and a mean value was obtained using the fol-
lowing criteria: a) intimal and adventitial inflammation: 0
= absence, 1 = scarce lymphocytes, 2 = scarce foci and 3 =
multiple or large foci of mononuclear infiltrate; b) Pres-
ence of hemorrhage, rupture or calcification of the plaque.
Quantitative analysis
The quantitative analysis was performed measuring the
most obstructive sample from the 3 sections in each case,
and for the extension of atherosclerosis all plaques from
the 3 sections were measured, as exemplified in Figure 2.
The most severely obstructed vessel segment was meas-
ured based on the knowledge that the shortest diameter
even in an oblique section of a tube is the same as the
diameter in a cross-section at right angles to the longitudi-
nal axis, fact that is referred to be valid also for wall thick-
ness and luminal vessel diameter [37]. Figure 2A shows
perpendicular measures, corresponding to the most
obstructive section. A flat shape of the lumen suggests that
the segment is collapsed despite of perfusion fixation.
Collapsing might have happened during the embedding
procedure. The three segments of each case measured
around 6 mm length with less than 1 mm thickness. They
were embedded in a same paraffin block and it was diffi-
cult to maintain them in perpendicular position. There-
fore during embedding in a same paraffin block it was
difficult to maintain them in perpendicular position and
the sections look oblique. An irregular morphology sug-
gesting a bifurcation area as exemplified in section 3, is
probably caused by a positive versus absent or negative
vessel remodeling induced by atherosclerosis develop-
ment [38,39]. In this section, the upper side represents a
fat plaque in both sides of the vessel, which is associated
with a positive vessel remodeling, and the inferior part, a
fibrotic plaque with no vessel remodeling.
The obstruction was evaluated by perpendicular measures
to the vessel long axis, obtaining external diameter,
plaque height, luminal diameter, % luminal obstruction
and % fat area in the plaque. The measurements were
made only in one plane, across the lowest diameter, in the
Masson's Trichrome and H&E slides, using the Leica -
Quantimet 500 Image Analysis System (Cambridge, UK),
by obtaining the following variables: a) vessel diameterBMC Microbiology 2009, 9:194 http://www.biomedcentral.com/1471-2180/9/194
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(distance comprised by the external elastic membrane); b)
potential luminal diameter (distance comprised by the
internal elastic membrane); c) height of the plaque, and
d) luminal diameter. The % luminal obstruction was cal-
culated using the formula: (potential luminal diameter -
luminal diameter)/potential luminal diameter × 100).
The % lipid content was calculated by measuring the non-
stained plaque regions (total plaque area less the fibro-
muscular area detected by automatic color detection).
Plaque area/internal surface
The extension of atherosclerosis was evaluated measuring
the total intimal area present in the three sections of the
case divided by the internal elastic membrane perimeter
(mm2/mm) ratio, as shown in Figures 2B and 2C.
Statistical analysis
Analysis of variance, Bonforroni and Dunn's tests were
used, with significance at P  0.05 (ANOVA test and
Dunn's for non-normally distributed values or Bonfer-
roni's test for normally distributed values). T test was used
when significance was not reached with ANOVA test in
order to point possible differences if only two groups were
compared.
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